Dr. Paul Sax weighs in on the important warning about dolutegravir and pregnancy in
HIV and ID Observations.
Multiple agencies, including the U.S. Department of Health and Human Services, FDA, and WHO, issued a warning about the HIV drug dolutegravir and pregnancy, citing an increased risk of neural tube defects in babies born to women who became pregnant while receiving the drug. In his latest HIV and ID Observations blog post, Dr. Paul Sax explains why this warning is so important — and what it means for women with HIV who want children.
Want to see more from NEJM Journal Watch? Register here.